Prime editing gene-correction therapy for PFIC1 and PFIC3 in patient-derived liver organoids
A gene-correction platform leveraging prime editing delivered via lipid nanoparticle-encapsulated modified RNA to treat progressive familial intrahepatic cholestasis types 1 and 3. The approach targets ABCB4 and ATP8B1 m...